Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$325K Sell
8,507
-3,524
-29% -$112K 0.23% 69
2025
Q4
$263K Buy
12,031
+2,508
+26% +$52.1K 0.14% 134
2025
Q3
$204K Buy
9,523
+1,278
+16% +$28.7K 0.11% 203
2025
Q2
$211K Buy
8,245
+4,177
+103% +$122K 0.12% 156
2025
Q1
$149K Buy
4,068
+4,066
+203,300% +$140K 0.1% 251
2024
Q4
$0 Hold
2
﹤0.01% 2215
2024
Q3
$0 Sell
2
-33
-94% -$1.27K ﹤0.01% 2196
2024
Q2
$1K Buy
35
+7
+25% +$227 ﹤0.01% 1924
2024
Q1
$1K Buy
28
+24
+600% +$807 ﹤0.01% 1896
2023
Q4
$0 Buy
4
+2
+100% +$65 ﹤0.01% 2128
2023
Q3
$0 Sell
2
-1
-33% -$31 ﹤0.01% 2097
2023
Q2
$0 Hold
3
﹤0.01% 2115
2023
Q1
$0 Hold
3
﹤0.01% 2000
2022
Q4
$0 Hold
3
﹤0.01% 2046
2022
Q3
$0 Sell
3
-1
-25% -$42 ﹤0.01% 1966
2022
Q2
$0 Buy
+4
New +$194 ﹤0.01% 1887
2022
Q1
Sell
-6
Closed 2086
2021
Q4
$0 Buy
+6
New +$364 ﹤0.01% 2100

Other funds holding ATEX

Covestor's ATEX Position: Q1 2026 in Review

Covestor reduced its Anterix (ATEX) stake by 29% in Q1 2026, selling an estimated $112K and leaving 8,507 shares worth $325K. The position accounts for 0.23% of the portfolio, ranked #69.

Covestor first reported a position in ATEX in Q4 2021 and has held it in 17 quarters since. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.

  • Covestor held 8,507 shares of Anterix worth $325K as of Q1 2026.
  • Covestor sold 3,524 Anterix shares in Q1 2026, an estimated $112K.
  • Anterix made up 0.23% of Covestor's portfolio in Q1 2026, its #69 holding.
  • Covestor first reported a position in Anterix in Q4 2021 and has held it in 17 quarters since.
  • 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.